Published in Am J Transplant on June 01, 2004
Spectrum of cancer risk among US solid organ transplant recipients. JAMA (2011) 4.99
Sensitivity of billing claims for cardiovascular disease events among kidney transplant recipients. Clin J Am Soc Nephrol (2009) 2.17
Effectiveness of a combination therapy using calcineurin inhibitor and mTOR inhibitor in preventing allograft rejection and post-transplantation renal cancer progression. Cancer Lett (2012) 2.05
Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation. J Am Soc Nephrol (2009) 1.72
Immune phenotype predicts risk for posttransplantation squamous cell carcinoma. J Am Soc Nephrol (2010) 1.72
Association of CKD and cancer risk in older people. J Am Soc Nephrol (2009) 1.57
Long-term cancer risk of immunosuppressive regimens after kidney transplantation. J Am Soc Nephrol (2010) 1.45
Skin changes following organ transplantation: an interdisciplinary challenge. Dtsch Arztebl Int (2014) 1.39
Cancer after renal transplantation: the next challenge. Am J Transplant (2004) 1.23
Chronic kidney disease and cancer: a troubling connection. J Nephrol (2010) 1.18
Risk of lymphoma subtypes after solid organ transplantation in the United States. Br J Cancer (2013) 1.17
Roles of the immune system in skin cancer. Br J Dermatol (2011) 1.12
Overexpression of vascular endothelial growth factor and the development of post-transplantation cancer. Cancer Res (2008) 1.11
Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease. Cancer Res (2009) 1.09
Melanoma in immunosuppressed patients. Mayo Clin Proc (2012) 1.07
Cancer screening in renal transplant recipients: what is the evidence? Clin J Am Soc Nephrol (2008) 1.06
Calcineurin inhibitors activate the proto-oncogene Ras and promote protumorigenic signals in renal cancer cells. Cancer Res (2009) 1.04
Variations in the risk for cerebrovascular events after kidney transplant compared with experience on the waiting list and after graft failure. Clin J Am Soc Nephrol (2008) 1.02
Combinations of immunotherapy and radiation in cancer therapy. Front Oncol (2014) 1.01
Renal cell cancer among African Americans: an epidemiologic review. BMC Cancer (2011) 1.01
Calcineurin inhibitors modulate CXCR3 splice variant expression and mediate renal cancer progression. J Am Soc Nephrol (2008) 1.00
Altered VEGF mRNA stability following treatments with immunosuppressive agents: implications for cancer development. J Biol Chem (2010) 0.99
Improved retroviral vector design results in sustained expression after adult gene therapy in mucopolysaccharidosis I mice. J Gene Med (2008) 0.99
A critical analysis of the tumour immunosurveillance controversy for 3-MCA-induced sarcomas. Br J Cancer (2009) 0.98
Malignancy after renal transplantation: the role of immunosuppression. Nat Rev Nephrol (2010) 0.98
ABO incompatible renal transplants: Good or bad? World J Transplant (2014) 0.97
Management and prevention of post-transplant malignancies in kidney transplant recipients. Clin Kidney J (2015) 0.97
Multiple bilateral oncocytomas of the native kidneys following renal transplantation: report of a rare case and review of the literature. World J Surg Oncol (2013) 0.96
Current principles of facial allotransplantation: the Brigham and Women's Hospital Experience. Plast Reconstr Surg (2013) 0.94
Tolerance to vascularized composite allografts in canine mixed hematopoietic chimeras. Transplantation (2011) 0.94
Current concepts and perspectives of immunosuppression in organ transplantation. Langenbecks Arch Surg (2007) 0.94
Calcineurin inhibitor-induced and Ras-mediated overexpression of VEGF in renal cancer cells involves mTOR through the regulation of PRAS40. PLoS One (2011) 0.93
Yield of screening colonoscopy in renal transplant candidates. Can J Gastroenterol Hepatol (2015) 0.93
Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens. Diagn Pathol (2012) 0.93
Importance of pre-transplant colonoscopy in renal transplant recipients. J Clin Med Res (2014) 0.91
Association of antibody induction immunosuppression with cancer after kidney transplantation. Transplantation (2015) 0.90
Cancer in patients on chronic dialysis in Korea. J Korean Med Sci (2009) 0.89
Incidence of malignancy after living kidney transplantation: a multicenter study from iran. J Cancer (2012) 0.89
The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients. Immunology (2015) 0.89
The natural product honokiol inhibits calcineurin inhibitor-induced and Ras-mediated tumor promoting pathways. Cancer Lett (2013) 0.88
Hodgkin lymphoma among US solid organ transplant recipients. Transplantation (2010) 0.88
Regression of advanced melanoma upon withdrawal of immunosuppression: case series and literature review. Med Oncol (2009) 0.88
The epidemic of nonmelanoma skin cancer and the widespread use of statins: Is there a connection? Dermatoendocrinol (2010) 0.86
Renal cell carcinoma of native kidney in Chinese renal transplant recipients: a report of 12 cases and a review of the literature. Int Urol Nephrol (2011) 0.86
Increased risk of post-transplant malignancy and mortality in transplant tourists: a nationwide population-based cohort study in Taiwan. Medicine (Baltimore) (2014) 0.85
JC virus infection in colorectal neoplasia that develops after liver transplantation. Clin Cancer Res (2008) 0.85
Donor transmitted and de novo cancer after liver transplantation. World J Gastroenterol (2014) 0.85
Melanoma Risk and Survival among Organ Transplant Recipients. J Invest Dermatol (2015) 0.85
Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy. Drug Des Devel Ther (2014) 0.84
Cancer diagnoses after living kidney donation: linking U.S. Registry data and administrative claims. Transplantation (2012) 0.84
Age, exclusion criteria, and generalizability of randomized trials enrolling kidney transplant recipients. Transplantation (2011) 0.83
Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation. Front Immunol (2015) 0.81
Transitional cell carcinoma of the kidney graft: an extremely uncommon presentation of tumor in renal transplant recipients. Case Rep Transplant (2013) 0.80
Aging and the immune response to organ transplantation. J Clin Invest (2017) 0.80
Demethylation of the TSDR is a marker of squamous cell carcinoma in transplant recipients. Am J Transplant (2014) 0.80
Antineoplastic effects of mammalian target of rapamycine inhibitors. World J Transplant (2012) 0.80
Haematuria in postrenal transplant patients. Biomed Res Int (2015) 0.80
Primary care of the renal transplant patient. J Gen Intern Med (2010) 0.80
Early diagnosis and treatment of breast cancer in Japanese kidney transplant recipients: a single center experience. Springerplus (2015) 0.80
Immunologic mechanisms in RCC and allogeneic renal transplant rejection. Nat Rev Urol (2010) 0.79
Clinical characteristics and treatment outcomes of colorectal cancer in renal transplant recipients in Korea. Yonsei Med J (2011) 0.79
Second malignancies in B-cell chronic lymphocytic leukaemia: possible association with human papilloma virus. Br J Haematol (2010) 0.79
Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database. PLoS One (2016) 0.78
Cancer incidence in kidney transplant recipients: a study protocol. BMC Cancer (2009) 0.78
The effect of sirolimus on prostate-specific antigen (PSA) levels in male renal transplant recipients without prostate cancer. Am J Transplant (2008) 0.78
Immunosenescence and organ transplantation. Transplant Rev (Orlando) (2013) 0.78
KNOW-KT (KoreaN cohort study for outcome in patients with kidney transplantation: a 9-year longitudinal cohort study): study rationale and methodology. BMC Nephrol (2014) 0.78
Incidence and clinicopathologic behavior of uterine cervical carcinoma in renal transplant recipients. World J Surg Oncol (2011) 0.78
Differential risks for adverse outcomes 3 years after kidney transplantation based on initial immunosuppression regimen: a national study. Transpl Int (2016) 0.78
Premalignant and Malignant Skin Lesions in Two Recipients of Vascularized Composite Tissue Allografts (Face, Hands). Case Rep Transplant (2015) 0.77
Epidemiological profile of nonmelanoma skin cancer in renal transplant recipients: experience of a referral center. An Bras Dermatol (2014) 0.77
Using Patient-Specific Induced Pluripotent Stem Cells and Wild-Type Mice to Develop a Gene Augmentation-Based Strategy to Treat CLN3-Associated Retinal Degeneration. Hum Gene Ther (2016) 0.77
BIOMARKERS OF OPERATIONAL TOLERANCE IN SOLID ORGAN TRANSPLANTATION. Expert Opin Med Diagn (2012) 0.77
Neoplastic disease after liver transplantation: Focus on de novo neoplasms. World J Gastroenterol (2015) 0.77
Malignancies after living-donor and cadaveric lung transplantations in Japanese patients. Surg Today (2016) 0.77
Prevalence of advanced colorectal neoplasm after kidney transplantation: surveillance based on the results of screening colonoscopy. Dig Dis Sci (2015) 0.77
Immune profiling and cancer post transplantation. World J Nephrol (2015) 0.77
Papillary renal carcinoma arising in an ectopic native kidney and status after renal transplant: a report of a unique case and review of the literature. Case Rep Pathol (2012) 0.77
Clinical significance of gastric cancer surveillance in renal transplant recipients. World J Surg (2012) 0.77
Cyclosporin-A associated malignancy. Clin Ophthalmol (2007) 0.76
Current progress in ABO-incompatible kidney transplantation. Kidney Res Clin Pract (2015) 0.76
Infliximab as long-term maintenance in steroid-resistant and recurrent sarcoidosis in a renal transplant with central nervous system involvement. Clin Kidney J (2012) 0.76
Clinical and economic consequences of first-year urinary tract infections, sepsis, and pneumonia in contemporary kidney transplantation practice. Transpl Int (2015) 0.76
Determination of optimal cholecalciferol treatment in renal transplant recipients using a population pharmacokinetic approach. Eur J Clin Pharmacol (2012) 0.76
Critical role of mTOR in calcineurin inhibitor-induced renal cancer progression. Cell Cycle (2012) 0.76
Minimally Invasive Colorectal Resection in Kidney Transplant Recipients: Technical Tips, Short- and Long-Term Outcomes. Int Sch Res Notices (2014) 0.75
Safety and immunologic benefits of conversion to sirolimus in kidney transplant recipients with long-term exposure to calcineurin inhibitors. Korean J Intern Med (2016) 0.75
More than skin deep? Potential nicotinamide treatment applications in chronic kidney transplant recipients. World J Transplant (2016) 0.75
Everolimus and Malignancy after Solid Organ Transplantation: A Clinical Update. J Transplant (2016) 0.75
Areca Nut Chewing and an Impaired Estimated Glomerular Filtration Rate as Significant Risk Factors for Non-Muscle-Invasive Bladder Cancer Recurrence. Sci Rep (2016) 0.75
Clinical and Economic Consequences of Early Cancer after Kidney Transplantation in Contemporary Practice. Transplantation (2016) 0.75
Immunogenicity of Human Papillomavirus Recombinant Vaccine in Children with CKD. Clin J Am Soc Nephrol (2016) 0.75
Clinical and Genetic Factors Associated with Cutaneous Squamous Cell Carcinoma in Kidney and Heart Transplant Recipients. Transplant Direct (2015) 0.75
Malignancies in a renal transplant population: The St. Michael's Hospital experience. Urol Ann (2016) 0.75
Adipocytokines in renal transplant recipients. Clin Kidney J (2016) 0.75
Cancer Incidence among Heart, Kidney, and Liver Transplant Recipients in Taiwan. PLoS One (2016) 0.75
Genetic barriers in transplantation medicine. World J Transplant (2016) 0.75
'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis (2012) 5.70
Spectrum of cancer risk among US solid organ transplant recipients. JAMA (2011) 4.99
Long interdialytic interval and mortality among patients receiving hemodialysis. N Engl J Med (2011) 4.62
Diabetes mellitus after kidney transplantation in the United States. Am J Transplant (2003) 4.39
An improved comorbidity index for outcome analyses among dialysis patients. Kidney Int (2009) 3.32
Excerpts from the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis (2010) 3.11
US Renal Data System 2010 Annual Data Report. Am J Kidney Dis (2011) 2.90
Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis (2005) 2.81
Differences in diabetes prevalence, incidence, and mortality among the elderly of four racial/ethnic groups: whites, blacks, hispanics, and asians. Diabetes Care (2004) 2.80
The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int (2004) 2.63
The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol (2009) 2.41
Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int Suppl (2003) 2.20
Scientific Registry of Transplant Recipients: collecting, analyzing, and reporting data on transplantation in the United States. Transplant Rev (Orlando) (2013) 2.19
Preemptive kidney transplantation: the advantage and the advantaged. J Am Soc Nephrol (2002) 2.19
Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2010) 2.18
Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis (2007) 2.16
United States Renal Data System 2008 Annual Data Report. Am J Kidney Dis (2009) 2.14
Issues regarding 'immortal time' in the analysis of the treatment effects in observational studies. Kidney Int (2011) 2.10
Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol (2010) 2.08
Survival in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. J Am Soc Nephrol (2012) 2.03
Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis (2008) 2.01
Hemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizations. Clin J Am Soc Nephrol (2006) 2.01
Cardiovascular risk factor profiles and kidney function stage in the US general population: the NHANES III study. Mayo Clin Proc (2005) 1.96
Effect of comorbidity on the increased mortality associated with early initiation of dialysis. Am J Kidney Dis (2005) 1.84
CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis (2008) 1.71
Hydrogen-treated TiO2 nanowire arrays for photoelectrochemical water splitting. Nano Lett (2011) 1.71
A comparison of transplant outcomes in peritoneal and hemodialysis patients. Kidney Int (2002) 1.71
Septicemia in the United States dialysis population, 1991 to 1999. J Am Soc Nephrol (2004) 1.70
Use of hospice in the United States dialysis population. Clin J Am Soc Nephrol (2006) 1.65
A simple tool to predict outcomes after kidney transplant. Am J Kidney Dis (2010) 1.63
Hypertension after kidney transplantation. Am J Kidney Dis (2004) 1.59
Infection-related hospitalization rates in pediatric versus adult patients with end-stage renal disease in the United States. J Am Soc Nephrol (2007) 1.58
Kidney function and risk triage in adults: threshold values and hierarchical importance. Kidney Int (2010) 1.57
Prehemodialysis care by dietitians and first-year mortality after initiation of hemodialysis. Am J Kidney Dis (2011) 1.57
Cardiovascular disease medications after renal transplantation: results from the Patient Outcomes in Renal Transplantation study. Transplantation (2011) 1.56
Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses. Am J Kidney Dis (2011) 1.53
Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES). Am J Kidney Dis (2009) 1.52
Does cadaveric donor renal transplantation ever provide better outcomes than live-donor renal transplantation? Transplantation (2003) 1.51
Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int (2005) 1.51
NHANES III: influence of race on GFR thresholds and detection of metabolic abnormalities. J Am Soc Nephrol (2007) 1.50
The Kidney Early Evaluation Program (KEEP): program design and demographic characteristics of the population. Am J Kidney Dis (2008) 1.46
Relative safety of peginesatide and epoetin alfa. Pharmacoepidemiol Drug Saf (2014) 1.43
Cost Implications of New National Allocation Policy for Deceased Donor Kidneys in the United States. Transplantation (2016) 1.42
Screening for chronic kidney disease complications in US adults: racial implications of a single GFR threshold. Clin J Am Soc Nephrol (2008) 1.41
Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int (2005) 1.41
Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999-2004. Am J Kidney Dis (2008) 1.38
CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis (2008) 1.37
Influenza vaccine delivery and effectiveness in end-stage renal disease. Kidney Int (2003) 1.36
Cystatin C levels in U.S. adults, 1988-1994 versus 1999-2002: NHANES. Clin J Am Soc Nephrol (2009) 1.31
Acute myocardial infarction and kidney transplantation. J Am Soc Nephrol (2006) 1.29
Does predialysis nephrology care influence patient survival after initiation of dialysis? Kidney Int (2005) 1.28
Body size and outcomes on peritoneal dialysis in the United States. Kidney Int (2003) 1.27
Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate. Int J Pharm (2005) 1.24
Depressive disorder in renal transplantation: an analysis of Medicare claims. Am J Kidney Dis (2008) 1.22
Liver sharing and organ procurement organization performance. Liver Transpl (2015) 1.21
Delayed hepatocellular carcinoma model for end-stage liver disease exception score improves disparity in access to liver transplant in the United States. Hepatology (2015) 1.20
The fall and rise of parathyroidectomy in U.S. hemodialysis patients, 1992 to 2002. J Am Soc Nephrol (2004) 1.18
Hemoglobin variability and mortality: confounding by disease severity. Am J Kidney Dis (2011) 1.16
Prevalence and associations of anemia of CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis (2008) 1.16
CKD surveillance using administrative data: impact on the health care system. Am J Kidney Dis (2009) 1.12
Diabetes mellitus in CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition and Examination Survey (NHANES) 1999-2004. Am J Kidney Dis (2008) 1.12
The relationship between kidney function and long-term graft survival after kidney transplant. Am J Kidney Dis (2011) 1.09
Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure. J Card Fail (2011) 1.07
Inadequate donor size in cadaver kidney transplantation. J Am Soc Nephrol (2002) 1.07
Carbon nanotubes promote neuron differentiation from human embryonic stem cells. Biochem Biophys Res Commun (2009) 1.06
Kidney function and sarcopenia in the United States general population: NHANES III. Am J Nephrol (2007) 1.06
Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction. J Am Coll Cardiol (2005) 1.05
Hospital treatment for fluid overload in the Medicare hemodialysis population. Clin J Am Soc Nephrol (2010) 1.04
Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease. Am J Kidney Dis (2009) 1.03
Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis (2008) 1.03
Association of provider-patient visit frequency and patient outcomes on hemodialysis. J Am Soc Nephrol (2012) 1.02
The role of procurement biopsies in acceptance decisions for kidneys retrieved for transplant. Clin J Am Soc Nephrol (2014) 1.02
Magnetic functionalised carbon nanotubes as drug vehicles for cancer lymph node metastasis treatment. Eur J Cancer (2011) 1.01
Blood transfusion use in non-dialysis-dependent chronic kidney disease patients aged 65 years and older. Nephrol Dial Transplant (2009) 1.01
Cause-specific mortality of dialysis patients after coronary revascularization: why don't dialysis patients have better survival after coronary intervention? Nephrol Dial Transplant (2008) 1.00
General medical care among patients with chronic kidney disease: opportunities for improving outcomes. J Am Soc Nephrol (2005) 1.00
Long-term survival of dialysis patients with bacterial endocarditis undergoing valvular replacement surgery in the United States. Circulation (2013) 1.00
Systematic study of the photoluminescence dependence of thiol-capped CdTe nanocrystals on the reaction conditions. J Phys Chem B (2005) 0.99
Comparison and survival of hemodialysis and peritoneal dialysis in the elderly. Semin Dial (2002) 0.99
Trends in patient characteristics and first-year medical costs of older incident hemodialysis patients, 1995-2005. Am J Kidney Dis (2010) 0.97
Efficient gene silencing induction in tomato by a viral satellite DNA vector. Virus Res (2007) 0.97
Association between number of months below K/DOQI haemoglobin target and risk of hospitalization and death. Nephrol Dial Transplant (2007) 0.97
Possible effects of the new Medicare reimbursement policy on African Americans with ESRD. J Am Soc Nephrol (2009) 0.97
Red blood cell transfusion use in patients with chronic kidney disease. Nephrol Dial Transplant (2013) 0.96
Survival of kidney transplantation patients in the United States after cardiac valve replacement. Circulation (2010) 0.96
Clinical epidemiology of long-bone fractures in patients receiving hemodialysis. Clin Orthop Relat Res (2007) 0.95
Hemoglobin levels and erythropoietin doses in hemodialysis and peritoneal dialysis patients in the United States. J Am Soc Nephrol (2004) 0.93
Overview of vaccination in chronic kidney disease. Adv Chronic Kidney Dis (2006) 0.93
Atherosclerotic renovascular disease in older US patients starting dialysis, 1996 to 2001. Circulation (2006) 0.92
Effects of monthly dose and regular dosing of intravenous active vitamin D use on mortality among patients undergoing hemodialysis. Pharmacotherapy (2009) 0.92
The influence of oxygen content on the thermal activation of hematite nanowires. Angew Chem Int Ed Engl (2012) 0.91
Magnetic colloidal supraparticles: design, fabrication and biomedical applications. Adv Mater (2013) 0.90
Cardiac evaluation before kidney transplantation: a practice patterns analysis in Medicare-insured dialysis patients. Clin J Am Soc Nephrol (2008) 0.90